永胜医疗(01612.HK)盈喜：预计年度公司拥有人应占综合溢利不少于1亿港元

Core Viewpoint - Yongsheng Medical (01612.HK) expects to record an unaudited consolidated profit attributable to owners of no less than HKD 100 million for the year ending December 31, 2025, compared to an audited profit of approximately HKD 69.2 million for the year ending December 31, 2024 [1] Group 1 - The anticipated profit increase is primarily attributed to strengthened relationships with a major customer in the imaging disposable products segment and the expansion of business scale, leading to a significant rise in revenue [1] - The company has achieved better economies of scale by enhancing capacity utilization and operational efficiency, which in turn has improved gross profit margins [1]